
CAS: 1509916-03-3
Ordinare per
3 prodotti.
Cergutuzumab
CAS:Cergutuzumab amunaleukin (CEA-IL2v) is an immunocytokine directed against carcinoembryonic antigen (CEA) containing an IL2v-moiety with abolished IL-2 receptor (IL-2R) α binding.Cergutuzumab Amunaleukin
CAS:Cergutuzumab amunaleukin (CEA-IL2v) is an immunocytokine directed against carcinoembryonic antigen (CEA) containing an IL2v-moiety with abolished IL-2 receptor (IL-2R) α binding.Cergutuzumab amunaleukin
CAS:Cergutuzumab amunaleukin (CEA-IL2v) is a CEA-targeted IL-2 variant immunocytokine for combination cancer immunotherapy with anti-tumor activity.Purezza:99.7% (SEC-HPLC) - 99.7% (SEC-HPLC)Colore e forma:LiquidPeso molecolare:162.05 kDa